相似文献
1
Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Cancer Control. 2017 Jul-Sep;24(3):1073274817729244. doi: 10.1177/1073274817729244.
2
Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis.
Surg Oncol Clin N Am. 2015 Jan;24(1):149-66. doi: 10.1016/j.soc.2014.09.004. Epub 2014 Oct 7.
3
Liver-directed therapy for hepatocellular carcinoma.
Abdom Radiol (NY). 2018 Jan;43(1):203-217. doi: 10.1007/s00261-017-1435-6.
4
Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
Ann Surg Oncol. 2012 Sep;19(9):2869-76. doi: 10.1245/s10434-012-2328-0. Epub 2012 Mar 27.
5
Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.
Ann Surg. 2002 Apr;235(4):466-86. doi: 10.1097/00000658-200204000-00004.
6
How does selective internal radiation therapy compare with and/or complement other liver-directed therapies.
Future Oncol. 2014 Nov;10(15 Suppl):105-9. doi: 10.2217/fon.14.236.
7
Treating unresectable intrahepatic cholangiocarcinoma with transarterial chemoembolization and an unusual progression with cardiac involvement.
Folia Med (Plovdiv). 2023 Apr 30;65(2):326-330. doi: 10.3897/folmed.65.e76329.
8
[Local and locoregional treatment of intrahepatic cholangiocarcinoma].
Radiologe. 2022 Mar;62(3):247-252. doi: 10.1007/s00117-021-00946-9. Epub 2022 Jan 3.
9
Management of Hepatocellular Carcinoma: Current Status and Future Directions.
Gut Liver. 2015 Jul;9(4):437-48. doi: 10.5009/gnl15022.
10
Arterially directed therapies for hepatocellular carcinoma.
AJR Am J Roentgenol. 2011 Oct;197(4):W590-602. doi: 10.2214/AJR.11.7554.
引用本文的文献
1
Clinical value of blood routine and tumor markers in differentiating hepatocellular carcinoma from intrahepatic cholangiocarcinoma.
Medicine (Baltimore). 2025 Mar 21;104(12):e41899. doi: 10.1097/MD.0000000000041899.
2
Transcatheter Arterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy Versus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Turk J Gastroenterol. 2024 Apr;35(4):266-279. doi: 10.5152/tjg.2024.23228.
3
Maximizing therapeutic outcomes in hepatocellular carcinoma: Insights into combinatorial strategies.
World J Gastrointest Oncol. 2024 Jul 15;16(7):2888-2893. doi: 10.4251/wjgo.v16.i7.2888.
4
Examining the Efficacy and Safety of Combined Locoregional Therapy and Immunotherapy in Treating Hepatocellular Carcinoma.
Biomedicines. 2024 Jun 27;12(7):1432. doi: 10.3390/biomedicines12071432.
5
Transarterial Chemoembolization Treatment Paradigms for Hepatocellular Carcinoma.
Cancers (Basel). 2024 Jul 1;16(13):2430. doi: 10.3390/cancers16132430.
6
Percutaneous liver-directed therapies of intrahepatic cholangiocarcinoma.
Abdom Radiol (NY). 2024 Dec;49(12):4257-4263. doi: 10.1007/s00261-024-04410-9. Epub 2024 Jun 20.
7
Effectiveness of Butorphanol in alleviating intra- and post-operative visceral pain following microwave ablation for hepatic tumor: a dual-central, randomized, controlled trial.
Sci Rep. 2024 Mar 19;14(1):6639. doi: 10.1038/s41598-024-56876-8.
8
Locoregional Therapy for Intrahepatic Cholangiocarcinoma: The Role of Intra-Arterial Therapies.
Cancers (Basel). 2023 Sep 26;15(19):4727. doi: 10.3390/cancers15194727.
9
Antitumor Activity of Metformin Combined with Locoregional Therapy for Liver Cancer: Evidence and Future Directions.
Cancers (Basel). 2023 Sep 13;15(18):4538. doi: 10.3390/cancers15184538.
10
Role of Percutaneous Ablation in the Management of Intrahepatic Cholangiocarcinoma.
Medicina (Kaunas). 2023 Jun 22;59(7):1186. doi: 10.3390/medicina59071186.
本文引用的文献
1
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
Gastroenterology. 2016 Dec;151(6):1155-1163.e2. doi: 10.1053/j.gastro.2016.08.029. Epub 2016 Aug 27.
2
High intensity focused ultrasound (HIFU) applied to hepato-bilio-pancreatic and the digestive system-current state of the art and future perspectives.
Hepatobiliary Surg Nutr. 2016 Aug;5(4):329-44. doi: 10.21037/hbsn.2015.11.03.
3
Management of hepatocellular carcinoma: an overview of major findings from meta-analyses.
Oncotarget. 2016 Jun 7;7(23):34703-51. doi: 10.18632/oncotarget.9157.
4
(90) Y radiation lobectomy: Outcomes following surgical resection in patients with hepatic tumors and small future liver remnant volumes.
J Surg Oncol. 2016 Jul;114(1):99-105. doi: 10.1002/jso.24269. Epub 2016 Apr 22.
5
Irreversible Electroporation in Interventional Oncology: Where We Stand and Where We Go.
Rofo. 2016 Aug;188(8):735-45. doi: 10.1055/s-0042-104203. Epub 2016 Apr 13.
6
Microwave versus Radiofrequency Ablation Treatment for Hepatocellular Carcinoma: A Comparison of Efficacy at a Single Center.
J Vasc Interv Radiol. 2016 May;27(5):631-8. doi: 10.1016/j.jvir.2016.01.136. Epub 2016 Mar 24.
7
Radiofrequency ablation versus resection for Barcelona clinic liver cancer very early/early stage hepatocellular carcinoma: a systematic review.
Ther Clin Risk Manag. 2016 Feb 23;12:295-303. doi: 10.2147/TCRM.S96760. eCollection 2016.
8
Percutaneous cryoablation of hepatic tumors: long-term experience of a large U.S. series.
Abdom Radiol (NY). 2016 Apr;41(4):767-80. doi: 10.1007/s00261-016-0687-x.
9
A comparison of survival in patients with hepatocellular carcinoma and portal vein invasion treated by radioembolization or sorafenib.
Liver Int. 2016 Aug;36(8):1206-12. doi: 10.1111/liv.13098. Epub 2016 Mar 23.
10
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone.
J Clin Oncol. 2016 Jun 10;34(17):2046-53. doi: 10.1200/JCO.2015.64.0821. Epub 2016 Feb 1.
Zotero 插件